Skip to main content
Clinical Trials/CTRI/2025/12/099584
CTRI/2025/12/099584Not yet recruitingNot Applicable

Effect of an Integrated Yoga Module on Mental Health and Quality of Life in Cancer Patients: A Randomized Controlled Trial

University of Patanjali1 site in 1 country136 target enrollmentStarted: January 6, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
136
Locations
1
Primary Endpoint
Anxiety, Depression, Quality of Sleep, Cognitive Emotion Regulation Questionnaire, Quality of Life

Study Overview

Brief Summary

This research examines how a structured yoga program can help cancer patients manage psychological stress during chemotherapy. Cancer patients often face significant anxiety, depression, sleep problems, and difficulty coping with their emotions while receiving treatment. Current approaches mainly use medications, which can cause additional side effects and dependency issues.

Our study offers a 12-week integrated yoga program specifically designed for patients undergoing active chemotherapy. The program combines gentle physical postures, breathing exercises, meditation, and mindfulness practices adapted to suit the physical limitations and needs of cancer patients. We aim to see whether this yoga intervention can meaningfully reduce anxiety and depression, improve sleep quality, enhance emotional coping skills, and boost overall quality of life.

The study will enroll 136 cancer patients from various cancer types who are currently receiving chemotherapy. Participants will be randomly assigned to either receive the yoga program immediately or continue with usual care and receive yoga after the study ends. We will measure changes in mental health, sleep, emotion regulation, and quality of life at the beginning and after 12 weeks.

This research addresses a critical gap because most previous studies focused only on breast cancer survivors after treatment ended, not on diverse cancer patients during the challenging active treatment phase. By understanding how yoga helps patients cope during chemotherapy, we hope to provide evidence-based support that can be integrated into routine cancer care to improve patients’ well-being alongside their medical treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
50.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Diagnosed with solid tumor malignancy Currently receiving chemotherapy treatment Life expectancy less then equals to 6 months Able to provide informed consent.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Anxiety, Depression, Quality of Sleep, Cognitive Emotion Regulation Questionnaire, Quality of Life

Time Frame: Pre-Data: January | Post-Data: April

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other [university]
Responsible Party
Principal Investigator
Principal Investigator

Ishani

University of Patanjali

Study Sites (1)

Loading locations...

Similar Trials